52 Biggest Movers From Yesterday

 

Gainers

  • Cumberland Pharmaceuticals Inc. CPIX shares climbed 128.6% to close at $5.03 on Tuesday. The FDA approved expanded labeling for Cumberland Pharmaceuticals’ Caldolor, an intravenously delivered formulation of ibuprofen, to now include use in pre-operative administration.
  • MEI Pharma, Inc. MEIP jumped 37.6% to settle at $3.37. MEI Pharma and Kyowa Kirin Co announced data from the pivotal Phase 2 TIDAL studyof zandelisib as a single agent for follicular lymphoma (FL) patients who received at least two prior systemic therapies.
  • Pioneer Power Solutions, Inc. PPSI shares gained 32.5% to close at $10.11 after dipping 27% on Monday.
  • NuZee, Inc. NUZE gained 31.4% to settle at $4.65.
  • ImmunoGen, Inc. IMGN jumped 29.9% to settle at $6.17 in reaction to positive topline data from the SORAYA trial of mirvetuximab soravtansine for ovarian cancer. The trial is evaluating mirvetuximab as monotherapy in patients with folate receptor alpha (FRα)-high platinum-resistant ovarian cancer who have been previously treated with Roche Holdings AG's RHHBY Avastin (bevacizumab).
  • Gritstone bio, Inc. GRTS gained 25.7% to close at $13.20 after the company announced the SARS-CoV-2 T cell epitopes administered within its self-amplifying mRNA COVID-19 vaccines are minimally impacted by the omicron variant.
  • Context Therapeutics Inc. CNTX shares rose 23.3% to close at $6.88 after climbing 9% on Monday.
  • Clene Inc. CLNN gained 22.4% to settle at $5.69.
  • Seres Therapeutics, Inc. MCRB jumped 22% to settle at $10.76. Seres Therapeutics said first patient was enrolled in Phase 1b study of SER-155 investigational microbiome therapeutic to reduce the risk of antibiotic-resistant bacterial infections and graft-versus-host disease.
  • ImmunityBio, Inc. IBRX gained 21.9% to settle at $7.79.
  • Cyteir Therapeutics, Inc. CYT gained 20% to close at $16.61. Cyteir Therapeutics, last month, posted a Q3 loss of $0.33 per share.
  • Molecular Partners AG MOLN climbed 17.8% to settle at $14.01 after the company confirmed retained activity of ensovibep on the positions mutated in emerging omicron variant of SARS-CoV-2 in vitro.
  • Vir Biotechnology, Inc. VIR gained 17.1% to close at $47.42 after HC Wainwright & Co maintained a Buy rating on the stock and raised its price target from $135 to $200.
  • Terns Pharmaceuticals, Inc. TERN surged 16.3% to settle at $7.55. Terns Pharmaceuticals, last month, posted a Q3 loss of $0.47 per share.
  • Armata Pharmaceuticals Inc. ARMP jumped 15.4% to close at $4.96.
  • Annexon, Inc. ANNX surged 15.1% to settle at $16.29. HC Wainwright & Co. initiated coverage on Annexon with a Buy rating and announced a price target of $40.
  • Crinetics Pharmaceuticals, Inc. CRNX jumped 14.3% to close at $27.32. JMP Securities initiated coverage on Crinetics Pharmaceuticals with a Market Outperform rating and announced a price target of $43.
  • Navigator Holdings Ltd. NVGS gained 14.1% to close at $9.13. Navigator Holdings posted Q3 EPS of $0.02.
  • ERYTECH Pharma S.A. ERYP gained 13.6% to close at $2.72 after the company secured US patent directed to sequential use of methioninase & asparaginase against solid tumors.
  • Adicet Bio, Inc. ACET surged 11.8% to close at $10.64.
  • Paltalk, Inc. PALT rose 11.7% to settle at $4.02.
  • Clarus Therapeutics Holdings, Inc. CRXT gained 9.8% to close at $5.72 after the company announced issuance of two new patents for JATENZO.
  • Chimerix, Inc. CMRX gained 7.3% to close at $6.29.
  • ContraFect Corporation CFRX gained 5.9% to close at $3.41.


Check out these big penny stock gainers and losers

Losers

  • AeroClean Technologies, Inc. AERC shares dipped 78.7% to close at $25.00 on Tuesday after jumping around 45% on Monday.
  • Olema Pharmaceuticals, Inc. OLMA shares fell 60.1% to close at $8.75 after the company announced first clinical data from the Phase 1 dose-escalation portion of the ongoing Phase 1/2 clinical trial of OP-1250.
  • TG Therapeutics, Inc. TGTX dipped 34.9% to settle at $15.20 after the company reported the FDA plans to host a meeting of the Oncologic Drugs Advisory Committee in connection with its review of the pending BLA/sNDA for the combination of ublituximab and UKONIQ.
  • Petros Pharmaceuticals, Inc. PTPI dipped 28.5% to close at $2.86 after surging over 91% on Monday.
  • Local Bounti Corporation LOCL fell 27% to close at $6.57.
  • Aesthetic Medical International Holdings Group Limited AIH dropped 23.1% to settle at $2.56. Aesthetic Medical Intl, last month, posted Q2 sales of $34.7 million.
  • JX Luxventure Limited LLL dropped 22% to settle at $2.66.
  • Array Technologies, Inc. ARRY fell 21.2% to close at $18.01 after the company reported a proposed private offering of $325 million of convertible senior notes.
  • Barnes & Noble Education, Inc. BNED fell 21% to close at $7.02 after the company reported worse-than-expected Q2 EPS and sales results.
  • Dillard's, Inc. DDS dipped 19.4% to close at $273.90.
  • RLX Technology Inc. RLX fell 18.9% to settle at $4.11.
  • NRx Pharmaceuticals, Inc. NRXP fell 17.5% to close at $6.68. NRx Pharmaceuticals rose 20% on Monday after the company announced positive data from its ZYESAMI study.
  • Palatin Technologies, Inc. PTN shares fell 16.4% to close at $0.7149 after gaining more than 50% on Monday.
  • Lizhi Inc. LIZI fell 15.9% to close at $2.12 after the company reported worse-than-expected Q3 sales results.
  • Biofrontera Inc. BFRI fell 15.6% to close at $5.99 following Q3 results.
  • Invacare Corporation IVC dropped 15.4% to settle at $2.74.
  • Unicycive Therapeutics, Inc. UNCY fell 15.4% to close at $2.14. Unicycive Therapeutics recently updated the development and regulatory filing pathway for Renazorb (lanthanum dioxycarbonate).
  • CTI BioPharma Corp. CTIC dropped 15.4% to settle at $2.25. CTI BioPharma announced extension of FDA review period for pacritinib in myelofibrosis with severe thrombocytopenia.
  • Dada Nexus Limited DADA dipped 15.4% to close at $18.07. Dada Group and Jiajiayue Group jointly launched the Online and Offline Chile E-commerce Festival.
  • ION Acquisition Corp 2 Ltd. IACB fell 15.2% to settle at $7.95
  • Pasithea Therapeutics Corp. KTTA fell 15.1% to close at $3.61.
  • Quoin Pharmaceuticals, Ltd. QNRX declined 15% to settle at $3.79.
  • StoneX Group Inc. SNEX dropped 14.6% to close at $56.17 following Q4 results.
  • BlueCity Holdings Limited BLCT fell 14.6% to close at $1.81.
  • Bluejay Diagnostics, Inc. BJDX dipped 14.1% to settle at $2.87. Bluejay Diagnostics, last month, priced its IPO at $10 per unit.
  • cbdMD, Inc. YCBD fell 13.4% to close at $1.68. CbdMD shares jumped 30% on Monday after the company announced a multi-year exclusive agreement with Amify, an Amazon.com platform partner.
  • Apogee Enterprises, Inc. APOG fell 10.3% to close at $41.30.
  • Baozun Inc. BZUN dipped 7.1% to close at $13.79 as the company reported third-quarter FY21 revenue growth of 3.8% year-on-year to $294.7 million (RMB1.9 billion), missing the consensus of $303.5 million.
Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: NewsPenny StocksSmall CapPre-Market OutlookMarketsMoversTrading IdeasAerospace & DefenseIndustrialsMovers From YesterdayTop Gainers
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!